Case Study:
Customer Excellence With AI Sales Rep Tools Brings in $937 Million in Incremental Growth
AI-Powered Sales Tool Delivers 43% Growth
Pharma sales reps have an increasingly difficult time. Whether their brand is a new launch, or there are competitor brands providing intense competition, or generic competition, the sales reps need to be armed with as much information on their therapy area and customers than ever before. The reps need the best information on everything possible, including predictions about their customers’ needs and behaviors.
The Client Problem
• Large, but older, brand in decline
• New brands with new treatment paradigms
• Generic competition
• Sales representatives felt they could not compete anymore
• Sales Director wanted to see if AI could give the reps a competitive edge
The Solution
• Rich individual physician level data within the CRM system
• Online data that could be linked to specific physicians
• Combined all data available into a uniform format, plus temporal sequencing
• Used AI techniques, thereafter, to create tools that provided actionable insights
• Physician switch warning behaviors sent to sales rep
• Bespoke sales message suggestion engine for individual physicians
• Bespoke detail aids for each physician created in the doctor’s office
The Outcome
• 43% increase in sales in reps using the system compared with the reps not using the system
• Was then rolled out to integrate into CRM system
• Overall incremental sales growth was $937 Million
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
What the EU AI Act Postponement Actually Means for Pharma AI Governance Globally
The timeline moved. The governance burden did not. On 7 May 2026, the European Parliament and the Council reached a provisional political agreement on the
The Copilot Delusion: Why “We Only Use Copilot” Is Not an AI Governance Strategy
Choosing one tool and writing a policy around it feels like control. Under the regulations now shaping pharma AI, it answers the wrong question entirely.
From Use Case to Working AI Agent Inside Your Pharma Environment
There is a specific pattern emerging across the pharmaceutical industry. Functional leaders in regulatory affairs, medical affairs, commercial, and market access have now seen enough